Research Article
HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
Table 2
HLA-G expression and cytogenetic karyotype.
| Patient number | FAB classification | Sex | Age | HLA-G expression |
Karyotype |
| 1 |
AML-M2 | F | 83 | Positive | 46XX +8[4];[16] | 3 | sAML | F | 69 | Negative | 46XX | 5 | AML-M4 | F | 54 | Positive | 46XX | 9 | AML-M4 | F | 44 | Negative | 46XX | 10 | AML-M2 | M | 60 | Positive | 46XY t(8; 21)(q22;q22), del(9)(q?22) | 11 | AML-M4 | M | 70 | Positive | 46XY[19]; +21[2]; iso p21[1] | 18 | AML-M2 | F | 68 | Negative | 46XX iso 8p | 19 | AML-M4 | F | 76 | Positive | 46XX | 20 | AML-M0 | F | 83 | Positive | 46XX −7/t(1;7;4;12)[12] | 21 | AML-M2 | F | 66 | Positive | 46XX +8[4];[16] | 23 | AML-M2 | M | 74 | Positive | 46XY | 34 | AML-M0 | F | 72 | Negative | 46XX | 36 | AML-M6 | M | 53 | Positive | 46XY complex(del5q,-10 14; 19, 7p-)[20] | 37 | AML-M2 | F | 59 | Negative | 46XX | 38 | AML | M | 59 | Positive | 46XY | 39 | AML-M1 | F | 47 | Negative | 46XX | 41 | AML-M4 | F | 41 | Negative | 46XY | 44 | AML | M | 36 | Positive | 46XY | 45 | AML-M4 | F | 44 | Positive | 46XX | 49 | AML-M2 | M | 77 | Positive | 46XY | 54 | AML-M3 | M | 22 | Positive | 46XY[6], t(15;17)[5] | 55 | AML-M5a | F | 58 | Positive | 46XX |
|
|